KemPharm is a clinical-stage pharmaceutical company that uses its innovative LAT platform technology to discover and develop prodrugs, with the goal of treating serious medical conditions. Its drug development focuses on improving efficacy and safety, thereby meeting critical unmet medical needs. KemPharm's goal is to make significant contributions to patient care through the development of new and effective therapies.
KemPharm Inc's ticker is KMPH
The company's shares trade on the NASDAQ stock exchange
They are based in Coralville, Iowa
There are 11-50 employees working at KemPharm Inc
It is kempharm.com
KemPharm Inc is in the Healthcare sector
KemPharm Inc is in the Biotechnology industry
The following five companies are KemPharm Inc's industry peers: